References
- Smith OW, Smith GV, Joslin EP, et al: Prolan and estrin in the serum and in the urine of diabetic and nondiabetic women with special reference to late pregnancy toxemia. Am J Obstet Gynecol 33:365, 1937
- Diczfalusy E, Troen P: Endocrine functions of the human placenta. Vitam Horm 19:229–311, 1961
- Villee CA: The placenta and fetal tissue: A cooperative enterprise for the synthesis of steroids. Isr J Med Sci 4:270, 1968
- Kahn CB, White P, Younger D: Laboratory assessment of diabetic pregnancy. Diabetes 21:31, 1972
- Ratanosopa V, Schindler AE, Lee TY, et al: Measurement of estriol in plasma by gas-liquid chromatography. Am J Obstet Gynecol 99:295, 1967
- Nachtigall L, Bassett M, Hogsander V, et al: Plasma estriol levels in normal and abnormal pregnancies: An index of fetal welfare. Am J Obstet Gynecol 101:638, 1968
- Reynolds JW: Assessment of fetal health by analysis of maternal steroids. J Pediatr 76:464, 1970
- Brown JB: Value of plasma estrogen estimations in the management of pregnancy. Clin Perinatol 1:273, 1974
- Beischer NA, O'Sullivan EF: Effect of rest and intravenous infusion of hypertonic dextrose on subnormal estriol excretion in pregnancy. Am J Obstet Gynecol 113:771, 1972
- White P: Diabetes mellitus and pregnancy. Clin Perinatol 1:331, 1974
- Selenkow HA, Varma A, Younger D, et al: Patterns of serum immunoreactive human placental lactogen (IR-HPL) and chorionic gonadotropin (IR-HCG) in diabetic pregnancy. Diabetes 20:696, 1971